Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence

B Aramini, V Masciale, G Grisendi, F Bertolini, M Maur… - Cancers, 2022 - mdpi.com
Simple Summary Cancer is one of the most debated problems all over the world. Cancer
stem cells are considered responsible of tumor initiation, metastasis, drug resistance, and …

Mesenchymal stem cells as a cornerstone in a galaxy of intercellular signals: basis for a new era of medicine

S Fernández-Francos, N Eiro, LA Costa… - International journal of …, 2021 - mdpi.com
Around 40% of the population will suffer at some point in their life a disease involving tissue
loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with …

Nanoparticle elasticity regulates the formation of cell membrane-coated nanoparticles and their nano-bio interactions

D Zou, Z Wu, X Yi, Y Hui, G Yang… - Proceedings of the …, 2023 - National Acad Sciences
Cell membrane-coated nanoparticles are emerging as a new type of promising
nanomaterials for immune evasion and targeted delivery. An underlying premise is that the …

Mesenchymal stem cells: A living carrier for active tumor-targeted delivery

T Zhang, R Lin, H Wu, X Jiang, J Gao - Advanced Drug Delivery Reviews, 2022 - Elsevier
The strategy of using mesenchymal stem cells (MSCs) as a living carrier for active delivery of
therapeutic agents targeting tumor sites has been attempted in a wide range of studies to …

Targeting nanoparticles to malignant tumors

N Sharma, K Bietar, U Stochaj - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Nanomaterials are at the forefront of health research and development. Among different
nanomaterials, nanoparticles are especially promising for cancer theranostics. However …

Endothelin-1 and its role in cancer and potential therapeutic opportunities

M Harrison, D Zinovkin, MZI Pranjol - Biomedicines, 2024 - mdpi.com
Endothelin-1 (ET-1) plays a physiological role as a potent vasoconstrictor. It is implicated in
an array of diseases, and its signalling is often found to be overactivated within cancers. ET …

[HTML][HTML] Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma

G Golinelli, G Grisendi, M Dall'Ora, G Casari… - Translational …, 2022 - Elsevier
Background Ewing's sarcoma (ES) is an aggressive cancer affecting children and young
adults. We pre-clinically demonstrated that mesenchymal stromal/stem cells (MSCs) can …

Cell therapy as target therapy against colon cancer stem cells

EN Garza Treviño, AG Quiroz Reyes… - International Journal of …, 2023 - mdpi.com
Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with properties,
such as self-renewal, differentiation, and tumorigenicity. CSCs have been proposed as a …

Time-Dependent Internalization of S100B by Mesenchymal Stem Cells via the Pathways of Clathrin- and Lipid Raft-Mediated Endocytosis

Y Zhang, J Zhu, H Xu, Q Yi, L Yan, L Ye… - Frontiers in Cell and …, 2021 - frontiersin.org
Mesenchymal stem cells (MSCs) are promising tools for cancer therapy, but there is a risk of
malignant transformation in their clinical application. Our previous work revealed that the …

Stem cell therapy for hepatocellular carcinoma and end-stage liver disease

MS Abdellateif, ARN Zekri - Journal of the Egyptian National Cancer …, 2023 - Springer
Hepatocellular carcinoma (HCC) is a major health problem worldwide, especially for
patients who are suffering from end-stage liver disease (ESLD). The ESLD is considered a …